Prince Charles opens new AstraZeneca research center
AstraZeneca has supplied two billion doses of its COVID-19 vaccine, developed at Oxford University, and is also looking to bring a preventative antibody cocktail against COVID-19 to market.
Prince Charles, son of Queen Elizabeth and heir to the throne, saw an exhibit on the pandemic and a demonstration of how augmented reality headsets can help with lab work, before hearing about the company's net-zero targets.
Chief Executive Pascal Soriot, who accompanied Charles on a tour through the facility, said the centre would "power the next stage of our company's growth."
AstraZeneca, which has a large portfolio of treatments for diseases such as cancer, heart disease and diabetes, said the centre would support research into specialized medicines and next-generation therapeutics, including gene-editing and cell therapies.